Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well as broadening their potential field of use.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$20.57
Change (%) Stock is Up 0.04 (0.19%)
Volume407,359
Data as of 05/25/16 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
05/10/16
Download Documentation Corporate Presentation May 2016

Recent News

More >>
DateTitle 
05/05/16Heron Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate ProgressPrinter Friendly Version
04/18/16Heron Therapeutics Provides Update on FDA Review of SUSTOL® NDAPrinter Friendly Version
03/17/16Heron Therapeutics Appoints David L. Szekeres, SVP Business Development, General Counsel and Corporate SecretaryPrinter Friendly Version
03/03/16Heron Therapeutics Provides Update on SUSTOL® NDA Printer Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.